MERSANA THERAPEUTICS INC shareholders Q3 2023

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

MERSANA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 5,000,000$6,350,0001.92%
VR Adviser, LLC 11,328,000$14,386,5601.51%
Bain Capital Life Sciences Investors, LLC 8,663,673$11,002,8651.23%
Affinity Asset Advisors, LLC 2,850,000$3,619,5001.02%
EcoR1 Capital, LLC 19,364,688$24,593,1540.83%
Altium Capital Management LP 1,059,136$1,345,1030.70%
5AM Venture Management, LLC 1,305,000$1,657,3500.48%
Decheng Capital Management III (Cayman), LLC 904,268$1,148,4200.38%
COMMODORE CAPITAL LP 2,244,378$2,850,3600.33%
Philosophy Capital Management LLC 2,342,634$2,975,1450.32%
SILVERARC CAPITAL MANAGEMENT, LLC 801,600$1,018,0320.31%
DAFNA Capital Management LLC 734,038$932,2280.29%
Ikarian Capital, LLC 1,579,770$2,006,3080.24%
Newtyn Management, LLC 700,000$889,0000.22%
Boxer Capital, LLC 2,000,000$2,540,0000.14%
Rock Springs Capital Management LP 3,403,133$4,321,9790.12%
Bellevue Group AG 5,218,625$6,627,6540.11%
Sarissa Capital Management LP 550,000$698,5000.09%
Atom Investors LP 293,177$372,3350.08%
ACUTA CAPITAL PARTNERS, LLC 99,607$126,5010.08%
External links

This page lists MERSANA THERAPEUTICS INC's shareholders in Q3 2023. To view MERSANA THERAPEUTICS INC's shareholder history, click here.